CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM NEW
Total 13F shares
1,001,411
Share change
+37,992
Total reported value
$21,513,868
Price per share
$21.48
Number of holders
32
Value change
+$837,395
Number of buys
12
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q4 2015

As of 31 Dec 2015, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,001,411 shares. The largest 10 holders included BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., NORTHERN TRUST CORP, STATE STREET CORP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Investment Management, LLC, Bank of New York Mellon Corp, TIAA CREF INVESTMENT MANAGEMENT LLC, and Zurcher Kantonalbank (Zurich Cantonalbank). This page lists 32 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.